Quinine Adco 300 mg Tablets
PDF Leaflet Revision Date: 22 September 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of resistant plasmodium falciparum malaria and muscle relaxant for myotonia.
Dosage (summary)
Adults: 300-600 mg at night for cramps; 600 mg every 8 hours for malaria. Children: 10 mg/kg every 8 hours.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Use in pregnancy is not contraindicated due to malaria risks.
Key Drug Interactions
- Mefloquine may increase side effects and seizures
Contraindications
- Hypersensitivity to quinine
- Tinnitus
- Optic neuritis
- Myasthenia gravis
Common side effects
- Cinchonism
- Tinnitus
- Nausea
- Vomiting
- Visual disturbances
Counselling Points
- Monitor for signs of cinchonism
- Avoid in myasthenia gravis
- Report any visual changes
Serious warnings
- Risk of seizures with mefloquine
- Cardiotoxicity in overdose
- Hypoglycaemia in malaria
Important Disclaimer
The Quinine Adco 300 mg Tablets professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
